FindTrial
Sign In

Study of Clinical Features of Patients with Tuberculosis admitted in a Pediatric Intensive Care Unit.

An Observational Study of Clinical Spectrum and Outcome of Patients with Tuberculosis in a Tertiary Care Pediatric Intensive Care Unit.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/02/050046
Enrollment
100
Registered
2023-02-24
Start date
Unknown
Completion date
Unknown
Last updated
2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A159- Respiratory tuberculosis unspecified Health Condition 2: A179- Tuberculosis of nervous system, unspecified Health Condition 3: A188- Tuberculosis of other specified organs

Interventions

None listed

Sponsors

No Sponsor MD Dissertation
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. All children aged 1month -12 years admitted to the PICU, diagnosed as Tuberculosis (TB) bacteriologically and clinically as per case definitions by the World health Organization (WHO). 2. Clinical diagnosis of TB meningitis will be as per the Doerr et al.9 classification. 3. Every readmission after discharge from the hospital (and the subsequent outcome&complications) will be considered as a separate event/ separate case enrolled.

Exclusion criteria

Exclusion criteria: Patients for whom the parents/guardians are not willing to give informed consent for participation. This is applicable only for the participants enrolled prospectively.Waiver of consent and assent will be requested for the retrospectively enrolled cases, as there will be no patient contact for these patients and all the data will be extracted from the indoor case sheets/ records only.

Design outcomes

Primary

MeasureTime frame
1. Frequency of category/ type of patients with Tuberculosis (pulmonary and extrapulmonary Tuberculosis- neurotuberculosis, abdominal TB, musculoskeletal TB, genitourinary TB, disseminated TB, TB lymphadenitis, others-cutaneous TB,TB laryngitis etc). 2. Percentage of primary system affected and the need for PICU admission. Timepoint: At discharge from the Pediatric intensive care unit or at death of the patient.—

Secondary

MeasureTime frame
1. Survival or death, cause of death, morbidity and sequelae at discharge. 2. Frequency of complications affecting each system and adverse effect of treatment. 3. Percentage of drug resistance pattern.Timepoint: At discharge from the Pediatric intensive care unit or at death of the patient.—

Countries

India

Contacts

Public ContactShivani Khadabadi

Seth G.S. Medical College and KEM Hospital

milindtullu@yahoo.com9869469974

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026